Roivant Sciences Ltd

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. They do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across their family of companies target a wide range of diseases…More including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. They focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs.